Brief: Metis Techbio Enters Strategic Collaboration With Lilly
BRIEF-Metis Techbio Enters Strategic Collaboration With Lilly Oct 19 (Reuters) - Metis TechBio Co., Ltd. 7666.HK:
METIS TECHBIO ENTERED STRATEGIC COLLABORATION WITH LILLY
COLLABORATION TO ADVANCE NEXT-GENERATION TISSUE-SPECIFIC LNP DELIVERY TECHNOLOGIES
ELIGIBLE FOR UPFRONT PAYMENT AND UP TO $1.10 BLN IN MILESTONE PAYMENTS
ELIGIBLE FOR SINGLE-DIGIT TIERED ROYALTIES ON ANNUAL NET SALES
Further company coverage: 7666.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eli Lilly and
See all newsUS stocks weekly: Spooky
Street View: Next-generation drugs bolster Lilly's growth outlook
US STOCKS-Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
US STOCKS-Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
US STOCKS-Wall Street slides as Alphabet revenue miss revives AI capex jitters